Aytu Biopharma (AYTU) EBT Margin Growth (1y) (2014 - 2026)
Powered by 
Analysis
Aytu Biopharma (AYTU) EBT Margin Growth (1y) (2014 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Margin Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 643.26 Bn | 622.50 Bn | 17.26 Bn | -68.00 |
| 2 | AbbVie | 443.31 Bn | 436.74 Bn | 12.70 Bn | 1,510.00 |
| 3 | Merck | 364.74 Bn | 357.60 Bn | 12.21 Bn | -3,574.00 |
| 4 | Novartis Ag | 266.46 Bn | 258.77 Bn | 11.24 Bn | -261.00 |
| 5 | Pfizer | 158.57 Bn | 146.88 Bn | 10.94 Bn | -2,512.00 |
| 6 | Sanofi | 52.33 Bn | 44.95 Bn | 10.79 Bn | -504.00 |
| 7 | Revolution Medicines | 43.79 Bn | 43.79 Bn | - | - |
| 8 | Incyte | 25.23 Bn | 20.69 Bn | 1.57 Bn | -101.00 |
| 9 | United Therapeutics | 21.67 Bn | 19.01 Bn | 683.80 Mn | -356.00 |
| 10 | Aytu Biopharma | 22.49 Mn | -4.22 Mn | 7.60 Mn | -6,588.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Mar 31, 2026 | -6,588.00 |
| Dec 31, 2025 | -7,215.00 |
| Sep 30, 2025 | 511.00 |
| Jun 30, 2025 | -11,108.00 |
| Mar 31, 2025 | 3,329.00 |
| Dec 31, 2024 | -511.00 |
| Sep 30, 2024 | 5,098.00 |
| Jun 30, 2024 | -939.00 |
| Mar 31, 2024 | 1,907.00 |
| Dec 31, 2023 | 3,293.00 |
| Sep 30, 2023 | -3,941.00 |
| Jun 30, 2023 | 5,062.00 |
| Mar 31, 2023 | 18,855.00 |
| Dec 31, 2022 | 2,448.00 |
| Sep 30, 2022 | 12,514.00 |
| Jun 30, 2022 | 2,119.00 |
| Dec 31, 2021 | 1,293.00 |
| Sep 30, 2021 | -9,583.00 |
| Jun 30, 2021 | -2,556.00 |
| Dec 31, 2020 | 12,170.00 |